Though VC investing is down, reloading on new funds is rising
...at this juncture, lets take a glimpse at the number of deals and deal size by company stage of development. Its obvious that deal sizes have ratcheted down substantially at all levels over the six-year period with the biggest drop in the start-up and seed segment. Likewise, the number of all over dea...BIO 2006 aftermath and a taste of bio-generics
...eying for worldwide position in the generic market by several major players: 1. Teva Pharmaceuticals - Headquartered outside of Tel Aviz, Israel, ratcheted up its worldwide presence by the acquisition of fellow generic company IVAX last year and Sicor the year before. 2. Sandoz Pharmaceuticals (a div...